TY - JOUR
T1 - Strategies for treatment of dystonia
AU - Dressler, Dirk
AU - Altenmueller, Eckart
AU - Bhidayasiri, Roongroj
AU - Bohlega, Saeed
AU - Chana, Pedro
AU - Chung, Tae Mo
AU - Frucht, Steven
AU - Garcia-Ruiz, Pedro J.
AU - Kaelin, Alain
AU - Kaji, Ryuji
AU - Kanovsky, Petr
AU - Laskawi, Rainer
AU - Micheli, Federico
AU - Orlova, Olga
AU - Relja, Maja
AU - Rosales, Raymond
AU - Slawek, Jaroslaw
AU - Timerbaeva, Sofia
AU - Warner, Thomas T.
AU - Saberi, Fereshte Adib
N1 - Publisher Copyright:
© 2015, Springer-Verlag Wien.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Treatment of dystonias is generally symptomatic. To produce sufficient therapy effects, therefore, frequently a multimodal and interdisciplinary therapeutic approach becomes necessary, combining botulinum toxin therapy, deep brain stimulation, oral antidystonic drugs, adjuvant drugs and rehabilitation therapy including physiotherapy, occupational therapy, re-training, speech therapy, psychotherapy and sociotherapy. This review presents the recommendations of the IAB—Interdisciplinary Working Group for Movement Disorders Special Task Force on Interdisciplinary Treatment of Dystonia. It reviews the different therapeutic modalities and outlines a strategy to adapt them to the dystonia localisation and severity of the individual patient. Hints to emerging and future therapies will be given.
AB - Treatment of dystonias is generally symptomatic. To produce sufficient therapy effects, therefore, frequently a multimodal and interdisciplinary therapeutic approach becomes necessary, combining botulinum toxin therapy, deep brain stimulation, oral antidystonic drugs, adjuvant drugs and rehabilitation therapy including physiotherapy, occupational therapy, re-training, speech therapy, psychotherapy and sociotherapy. This review presents the recommendations of the IAB—Interdisciplinary Working Group for Movement Disorders Special Task Force on Interdisciplinary Treatment of Dystonia. It reviews the different therapeutic modalities and outlines a strategy to adapt them to the dystonia localisation and severity of the individual patient. Hints to emerging and future therapies will be given.
KW - Antidystonic drugs
KW - Botulinum toxin
KW - Deep brain stimulation
KW - Dystonia
KW - Interdisciplinary approach
KW - Multimodal therapies
KW - Rehabilitation therapy
KW - Treatment strategies
UR - http://www.scopus.com/inward/record.url?scp=84959086030&partnerID=8YFLogxK
U2 - 10.1007/s00702-015-1453-x
DO - 10.1007/s00702-015-1453-x
M3 - Review article
C2 - 26370676
AN - SCOPUS:84959086030
SN - 0300-9564
VL - 123
SP - 251
EP - 258
JO - Journal of Neural Transmission
JF - Journal of Neural Transmission
IS - 3
ER -